Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For:	Chandler R, de Bono J. Second-generation antiandrogens in nonmetastatic CRPC. Nat Rev Urol 2018;15:342-344. [PMID: 29666457 DOI: 10.1038/s41585-018-0007-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]

Number

Cited by Other Article(s)

Apalutamide in non-metastatic castration-resistant prostate cancer: a profile of its use. DRUGS & THERAPY PERSPECTIVES 2020. [DOI: 10.1007/s40267-020-00707-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]

Zhao H, Freedland S. Enzalutamide treatment for the whole spectrum of CRPC. Nat Rev Urol 2019;15:663-665. [PMID: 30242270 DOI: 10.1038/s41585-018-0090-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]

Apalutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer. Drugs 2019;79:1591-1598. [DOI: 10.1007/s40265-019-01194-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]